Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

US Patent 11932852 · Granted Mar 19, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for synthetic biomarkers2025
Methods and compositions for synthetic biomarkers2024
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof2022
Adeno-associated virus (AAV) with modified phospholipase domain2022
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use ther2022
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use ther2021
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use ther2021
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof2021
Age-related macular degeneration treatment2018
RNAi expression constructs2015
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents2014
Multiple promoter expression cassettes for simultaneous delivery of RNAi agents2012